220 related articles for article (PubMed ID: 24583629)
1. Genome-wide analysis of methotrexate pharmacogenomics in rheumatoid arthritis shows multiple novel risk variants and leads for TYMS regulation.
Senapati S; Singh S; Das M; Kumar A; Gupta R; Kumar U; Jain S; Juyal RC; Thelma BK
Pharmacogenet Genomics; 2014 Apr; 24(4):211-9. PubMed ID: 24583629
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in the thymidylate synthase and methylenetetrahydrofolate reductase genes and sensitivity to the low-dose methotrexate therapy in patients with rheumatoid arthritis.
Kumagai K; Hiyama K; Oyama T; Maeda H; Kohno N
Int J Mol Med; 2003 May; 11(5):593-600. PubMed ID: 12684695
[TBL] [Abstract][Full Text] [Related]
3. Effect of thymidylate synthase (TYMS) gene polymorphisms with methotrexate treatment outcome in south Indian Tamil patients with rheumatoid arthritis.
Muralidharan N; Misra DP; Jain VK; Negi VS
Clin Rheumatol; 2017 Jun; 36(6):1253-1259. PubMed ID: 28349270
[TBL] [Abstract][Full Text] [Related]
4. Role of key TYMS polymorphisms on methotrexate therapeutic outcome in portuguese rheumatoid arthritis patients.
Lima A; Seabra V; Bernardes M; Azevedo R; Sousa H; Medeiros R
PLoS One; 2014; 9(10):e108165. PubMed ID: 25279663
[TBL] [Abstract][Full Text] [Related]
5. Common polymorphisms in the folate pathway predict efficacy of combination regimens containing methotrexate and sulfasalazine in early rheumatoid arthritis.
James HM; Gillis D; Hissaria P; Lester S; Somogyi AA; Cleland LG; Proudman SM
J Rheumatol; 2008 Apr; 35(4):562-71. PubMed ID: 18322994
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate (MTX) pathway gene polymorphisms and their effects on MTX toxicity in Caucasian and African American patients with rheumatoid arthritis.
Ranganathan P; Culverhouse R; Marsh S; Mody A; Scott-Horton TJ; Brasington R; Joseph A; Reddy V; Eisen S; McLeod HL
J Rheumatol; 2008 Apr; 35(4):572-9. PubMed ID: 18381794
[TBL] [Abstract][Full Text] [Related]
7. Association of dihydrofolate reductase (DHFR) -317AA genotype with poor response to methotrexate in patients with rheumatoid arthritis.
Milic V; Jekic B; Lukovic L; Bunjevacki V; Milasin J; Novakovic I; Damnjanovic T; Popovic B; Maksimovic N; Damjanov N; Radunovic G; Pejnovic N; Krajinovic M
Clin Exp Rheumatol; 2012; 30(2):178-83. PubMed ID: 22324981
[TBL] [Abstract][Full Text] [Related]
8. ABCB1 C3435T polymorphism influences methotrexate sensitivity in rheumatoid arthritis patients.
Takatori R; Takahashi KA; Tokunaga D; Hojo T; Fujioka M; Asano T; Hirata T; Kawahito Y; Satomi Y; Nishino H; Tanaka T; Hirota Y; Kubo T
Clin Exp Rheumatol; 2006; 24(5):546-54. PubMed ID: 17181924
[TBL] [Abstract][Full Text] [Related]
9. Genetic Determinants of Methotrexate Toxicity in Tunisian Patients with Rheumatoid Arthritis: A Study of Polymorphisms Involved in the MTX Metabolic Pathway.
Chaabane S; Marzouk S; Akrout R; Ben Hamad M; Achour Y; Rebai A; Keskes L; Fourati H; Bahloul Z; Maalej A
Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):385-93. PubMed ID: 26077125
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in genes involved in the mechanism of action of methotrexate: are they associated with outcome in rheumatoid arthritis patients?
Salazar J; Moya P; Altés A; Díaz-Torné C; Casademont J; Cerdà-Gabaroi D; Corominas H; Baiget M
Pharmacogenomics; 2014 Jun; 15(8):1079-90. PubMed ID: 25084201
[TBL] [Abstract][Full Text] [Related]
11. Association of the TYMS 3G/3G genotype with poor response and GGH 354GG genotype with the bone marrow toxicity of the methotrexate in RA patients.
Jekic B; Lukovic L; Bunjevacki V; Milic V; Novakovic I; Damnjanovic T; Milasin J; Popovic B; Maksimovic N; Damjanov N; Radunovic G; Kovacevic L; Krajinovic M
Eur J Clin Pharmacol; 2013 Mar; 69(3):377-83. PubMed ID: 22763757
[TBL] [Abstract][Full Text] [Related]
12. Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis.
Dervieux T; Furst D; Lein DO; Capps R; Smith K; Walsh M; Kremer J
Arthritis Rheum; 2004 Sep; 50(9):2766-74. PubMed ID: 15457444
[TBL] [Abstract][Full Text] [Related]
13. TYMS polymorphisms and responsiveness to or toxicity of methotrexate in rheumatoid arthritis.
Bae SC; Lee YH
Z Rheumatol; 2018 Nov; 77(9):824-832. PubMed ID: 29380036
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes.
Wessels JA; de Vries-Bouwstra JK; Heijmans BT; Slagboom PE; Goekoop-Ruiterman YP; Allaart CF; Kerstens PJ; van Zeben D; Breedveld FC; Dijkmans BA; Huizinga TW; Guchelaar HJ
Arthritis Rheum; 2006 Apr; 54(4):1087-95. PubMed ID: 16572443
[TBL] [Abstract][Full Text] [Related]
15. Functional polymorphisms and methotrexate treatment outcome in recent-onset rheumatoid arthritis.
Kooloos WM; Wessels JA; van der Straaten T; Allaart CF; Huizinga TW; Guchelaar HJ
Pharmacogenomics; 2010 Feb; 11(2):163-75. PubMed ID: 20136356
[TBL] [Abstract][Full Text] [Related]
16. Gene-gene interactions in folate and adenosine biosynthesis pathways affect methotrexate efficacy and tolerability in rheumatoid arthritis.
Dervieux T; Wessels JA; van der Straaten T; Penrod N; Moore JH; Guchelaar HJ; Kremer JM
Pharmacogenet Genomics; 2009 Dec; 19(12):935-44. PubMed ID: 19858780
[TBL] [Abstract][Full Text] [Related]
17. Are Thymidylate synthase and Methylene tetrahydrofolate reductase genes linked with methotrexate response (efficacy, toxicity) in Indian (Asian) rheumatoid arthritis patients?
Ghodke Y; Chopra A; Joshi K; Patwardhan B
Clin Rheumatol; 2008 Jun; 27(6):787-9. PubMed ID: 18274813
[TBL] [Abstract][Full Text] [Related]
18. The impact of folate pathway variants on the outcome of methotrexate therapy in rheumatoid arthritis patients.
Nomair AM; Abdelati A; Dwedar FI; Elnemr R; Kamel YN; Nomeir HM
Clin Rheumatol; 2024 Mar; 43(3):971-983. PubMed ID: 38311638
[TBL] [Abstract][Full Text] [Related]
19.
Sundbaum JK; Baecklund E; Eriksson N; Hallberg P; Kohnke H; Wadelius M
Pharmacogenomics; 2020 Apr; 21(5):337-346. PubMed ID: 32024416
[No Abstract] [Full Text] [Related]
20. Exploratory analysis of four polymorphisms in human GGH and FPGS genes and their effect in methotrexate-treated rheumatoid arthritis patients.
van der Straaten RJ; Wessels JA; de Vries-Bouwstra JK; Goekoop-Ruiterman YP; Allaart CF; Bogaartz J; Tiller M; Huizinga TW; Guchelaar HJ
Pharmacogenomics; 2007 Feb; 8(2):141-50. PubMed ID: 17286537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
